Conmed (CNMD) Tops Q4 EPS by 4c, Beats on Revenues; Offers FY18 EPS Outlook Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. CDNS
2. AVGO
3. SPY
4. META
5. JBLU
6. ANT
7. SSD
8. ARTV
9. AAPL
10. INTC

Go back to Conmed (CNMD) Tops Q4 EPS by 4c, Beats on Revenues; Offers FY18 EPS Outlook Above Consensus

CONMED (CNMD) PT Raised to $54 at Piper Jaffray

February 1, 2018 6:41 AM EST

Piper Jaffray raised its price target on CONMED (NASDAQ: CNMD) to $54.00 (from $46.00) while maintaining a Neutral rating.

... More

CONMED (CNMD) PT Raised to $71 at Needham & Company

February 1, 2018 6:22 AM EST

Needham & Company raised its price target on CONMED (NASDAQ: CNMD) to $71.00 (from $58.00) while maintaining a Buy rating.

Analyst Mike Matson commented, "CNMD's 4Q17 revenue and EPS beat consensus and management guided to above-consensus 2018 revenue and EPS. Its revenue growth improved to... More